Infliximab and biosimilar infliximab in psoriasis: efficacy, loss of efficacy, and adverse events

Subedi, S; Gong, Y; Chen, YD; Shi, YL

Shi, YL (reprint author), Tongji Univ, Shanghai Peoples Hosp 10, Dept Dermatol, Sch Med, YanChang Rd 301, Shanghai 200072, Peoples R China.; Shi, YL (reprint author), Tongji Univ, Inst Psoriasis, Sch Med, YanChang Rd 301, Shanghai 200072, Peoples R China.

DRUG DESIGN DEVELOPMENT AND THERAPY, 2019; 13 (): 2491

Abstract

Psoriasis is a chronic immune-mediated skin disease affecting multiple systems, and tumor necrosis factor-alpha (TNF-alpha) plays a significant role i......

Full Text Link